DB-1310

Other Medications

1 Clinical Trials

Description

DB-1310 is an investigational medication currently being studied in clinical trials for advanced solid tumors, including colorectal cancer. It is being tested in Phase 1 trials to determine the safest dose (Maximum Tolerated Dose or MTD) and the recommended dose for further studies. These trials are evaluating DB-1310 both alone (monotherapy) and in combination with other cancer drugs like trastuzumab, osimertinib, and capecitabine. The trials are designed to assess the safety and tolerability of DB-1310 and to look for early signs of effectiveness in patients with certain types of advanced solid tumors. The specific types of tumors being studied and the criteria for patient selection (like HER2 expression) may vary between trials.

Mechanism of Action

DB-1310 is being investigated as a potential treatment for advanced solid tumors. The specific way it works (its mechanism of action) is still being studied in clinical trials. It is being tested alone and in combination with other drugs to see how it affects cancer cells and the body's response.

Side Effects

As DB-1310 is an investigational drug in early-phase clinical trials (Phase 1) The full range of potential side effects is still being evaluated. The primary goal of Phase 1 trials is to assess safety and determine the highest dose that can be given without unacceptable side effects. Information about specific side effects observed in these trials is not yet widely available But common side effects for drugs in this class or used in combination (like trastuzumab Osimertinib Capecitabine) can include fatigue Nausea Diarrhea Skin reactions And effects on blood counts. Patients participating in these trials are closely monitored for any adverse events.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT05785741 Phase 1
Recruiting
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
United States, China

Quick Info

CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
786 trials
Leucovorin
Other Medications
647 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.